SANUWAVE Health, Inc. (NASDAQ:SNWV) Director Anthony Michael Stolarski bought 500,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 28th. The shares were purchased at an average price of $0.06 per share, for a total transaction of $30,000.00. Following the transaction, the director now owns 3,724,626 shares of the company’s stock, valued at approximately $223,477.56. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Shares of SANUWAVE Health, Inc. (NASDAQ:SNWV) opened at 0.15 on Tuesday. The company’s 50-day moving average is $0.13 and its 200-day moving average is $0.07. The firm’s market cap is $15.75 million. SANUWAVE Health, Inc. has a 12 month low of $0.03 and a 12 month high of $0.17.

SANUWAVE Health Company Profile

SANUWAVE Health, Inc is an acoustic pressure shock wave technology company using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The Company is focused on regenerative medicine utilizing noninvasive (extracorporeal), acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures.

5 Day Chart for NASDAQ:SNWV

Receive News & Ratings for SANUWAVE Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SANUWAVE Health Inc. and related companies with's FREE daily email newsletter.